Jurriaan Dekkers
Finanzdirektor/CFO bei PROQR THERAPEUTICS N.V.
Profil
Jurriaan Dekkers is the founder of Dr. Decorum.
He is currently the Chief Financial Officer at ProQR Therapeutics NV since 2022.
He is also a Member-Supervisory Board at Stichting Kinderpostzegels Nederland.
Previously, he worked as the Chief Financial Officer & Director at Acerta Pharma BV and as the Chief Financial Officer at AstraZeneca BV.
He graduated from Rotterdam University.
Aktive Positionen von Jurriaan Dekkers
Unternehmen | Position | Beginn |
---|---|---|
PROQR THERAPEUTICS N.V. | Finanzdirektor/CFO | 01.10.2022 |
Stichting Kinderpostzegels Nederland | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Jurriaan Dekkers
Unternehmen | Position | Ende |
---|---|---|
Dr. Decorum | Gründer | - |
AstraZeneca BV | Finanzdirektor/CFO | - |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Vorstandsvorsitzender | - |
Ausbildung von Jurriaan Dekkers
Rotterdam University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PROQR THERAPEUTICS N.V. | Health Technology |
Private Unternehmen | 4 |
---|---|
Stichting Kinderpostzegels Nederland | Miscellaneous |
AstraZeneca BV | |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Health Technology |
Dr. Decorum |